Deferred Tax Assets, Valuation Allowance of PLIANT THERAPEUTICS, INC. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
PLIANT THERAPEUTICS, INC. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • PLIANT THERAPEUTICS, INC. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2025 was $229,548,000, a 16% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

PLIANT THERAPEUTICS, INC. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $229,548,000 +$31,050,000 +16% 31 Dec 2025 10-K 11 Mar 2026 2025 FY
Q4 2024 $198,498,000 +$44,557,000 +29% 31 Dec 2024 10-K 11 Mar 2026 2025 FY
Q4 2023 $153,941,000 +$48,257,000 +46% 31 Dec 2023 10-K 11 Mar 2026 2025 FY
Q4 2022 $105,684,000 +$38,000,000 +56% 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q4 2021 $67,684,000 +$32,243,000 +91% 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q4 2020 $35,441,000 +$13,512,000 +62% 31 Dec 2020 10-K 09 Mar 2023 2022 FY
Q4 2019 $21,929,000 +$1,689,000 +8.3% 31 Dec 2019 10-K 01 Mar 2022 2021 FY
Q4 2018 $20,240,000 31 Dec 2018 10-K 16 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.